Predicting the solubility-permeability interplay when using cyclodextrins in solubility-enabling formulations: Model validation

International Journal of Pharmaceutics

Volumn 430, Issue 1-2, 2012, Pages 388-391

  Miller, Jonathan M ^a   Dahan, Arik ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Cyclodextrins; Intestinal permeability; Low solubility drugs; Oral drug delivery; Solubility permeability interplay; Solubility permeability tradeoff

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; PROGESTERONE;

ARTICLE; DRUG FORMULATION; DRUG PENETRATION; DRUG SOLUBILITY; PREDICTION; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; BETA-CYCLODEXTRINS; CARBAMAZEPINE; CHEMISTRY, PHARMACEUTICAL; EXCIPIENTS; HYDROCORTISONE; INTESTINAL ABSORPTION; MODELS, CHEMICAL; PERMEABILITY; PROGESTERONE; REPRODUCIBILITY OF RESULTS; SOLUBILITY; TECHNOLOGY, PHARMACEUTICAL;

EID: 84860702965     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.03.017     Document Type: Article

References (23)

1. G.L. Amidon, H. Lennernas, V.P. Shah, and J.R. Crison A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability Pharm. Res. 12 1995 413
2. A. Beig, J.M. Miller, and A. Dahan Accounting for the solubility-permeability interplay in oral formulation development for poor water solubility drugs: the effect of PEG-400 on carbamazepine absorption Eur. J. Pharm. Biopharm. 2012 10.1016/j.ejpb.2012.02.012
3. M.E. Brewster, and T. Loftsson Cyclodextrins as pharmaceutical solubilizers Adv. Drug Deliv. Rev. 59 2007 645 666 (Pubitemid 47299263)
4. M.E. Brewster, M. Noppe, J. Peeters, and T. Loftsson Effect of the unstirred water layer on permeability enhancement by hydrophilic cyclodextrins Int. J. Pharm. 342 2007 250 253 (Pubitemid 47263497)
5. R.L. Carrier, L.A. Miller, and I. Ahmed The utility of cyclodextrins for enhancing oral bioavailability J. Control. Release 123 2007 78
6. J.R. Crison, V.P. Shah, J.P. Skelly, and G.L. Amidon Drug dissolution into micellar solutions: development of a convective diffusion model and comparison to the film equilibrium model with application to surfactant-facilitated dissolution of carbamazepine J. Pharm. Sci. 85 1996 1005 1011 (Pubitemid 26300231)
7. A. Dahan, and J.M. Miller The solubility-permeability interplay and its implications in formulation design and development for poorly soluble drugs AAPS J. 2012 10.1208/s12248-012-9337-6
8. A. Dahan, J.M. Miller, and G.L. Amidon Prediction of solubility and permeability class membership: provisional BCS classification of the world's top oral drugs AAPS J. 11 2009 740 746
9. A. Dahan, J.M. Miller, J.M. Hilfinger, S. Yamashita, L.X. Yu, H. Lennernäs, and G.L. Amidon High-permeability criterion for BCS classification: segmental/pH dependent permeability considerations Mol. Pharm. 7 2010 1827 1834
10. A. Dahan, J.M. Miller, A. Hoffman, G.E. Amidon, and G.L. Amidon The solubility-permeability interplay in using cyclodextrins as pharmaceutical solubilizers: mechanistic modeling and application to progesterone J. Pharm. Sci. 99 2010 2739 2749
11. M.E. Davis, and M.E. Brewster Cyclodextrin-based pharmaceutics: past, present and future Nat. Rev. Drug Discov. 3 2004 1023
12. H. Lennernas Human intestinal permeability J. Pharm. Sci. 87 1998 403 410 (Pubitemid 28175799)
13. T. Loftsson, and M.E. Brewster Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization J. Pharm. Sci. 85 1996 1017 1025 (Pubitemid 26338912)
14. T. Loftsson, M.E. Brewster, and M. Masson Role of cyclodextrins in improving oral drug delivery Am. J. Drug Deliv. 2 2004 261
15. T. Loftsson, and D. Duchêne Cyclodextrins and their pharmaceutical applications Int. J. Pharm. 329 2007 1 11 (Pubitemid 44937538)
16. T. Loftsson, P. Jarho, M. Másson, and T. Järvinen Cyclodextrins in drug delivery Expert Opin. Drug Deliv. 2 2005 335 351 (Pubitemid 41130887)
17. T. Loftsson, S.B. Vogensen, M.E. Brewster, and F. Konrásdó ttir Effects of cyclodextrins on drug delivery through biological membranes J. Pharm. Sci. 96 2007 2532 2546 (Pubitemid 47597809)
18. J.M. Miller, A. Beig, R.A. Carr, G.K. Webster, and A. Dahan The solubility-permeability interplay when using cosolvents for solubilization: revising the way we use solubility-enabling formulations Mol. Pharm. 9 2012 581 590
19. J.M. Miller, A. Beig, B.J. Krieg, R.A. Carr, T.B. Borchardt, G.E. Amidon, G.L. Amidon, and A. Dahan The solubility-permeability interplay: mechanistic modeling and predictive application of the impact of micellar solubilization on intestinal permeation Mol. Pharm. 8 2011 1848 1856
20. R.A. Rajewski, and V.J. Stella Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery J. Pharm. Sci. 85 1996 1142 1169 (Pubitemid 26372882)
21. V.M. Rao, and V.J. Stella When can cyclodextrins be considered for solubilization purposes? J. Pharm. Sci. 92 2003 927 932 (Pubitemid 36523437)
22. A.C.F. Ribeiro, A.J.M. Valente, C.I.A.V. Santos, P.M.R.A. Prazeres, V.M.M. Lobo, H.D. Burrows, M.A. Esteso, A.M.T.D.P.V. Cabral, and F.J.B. Veiga Binary mutual diffusion coefficients of aqueous solutions of α-cyclodextrin, 2-hydroxypropyl-α-cyclodextrin, and 2-hydroxypropyl-β-cyclodextrin at temperatures from (298.15 to 312.15) K J. Chem. Eng. Data 52 2007 586 590 (Pubitemid 46486600)
23. T. Seki, J. Mochida, M. Okamoto, O. Hosoya, K. Juni, and K. Morimoto Measurement of diffusion coefficients of parabens and steroids in water and 1-octanol Chem. Pharm. Bull. 51 2003 734 736 (Pubitemid 41672742)